1. Home
  2. UFPT vs AUPH Comparison

UFPT vs AUPH Comparison

Compare UFPT & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UFP Technologies Inc.

UFPT

UFP Technologies Inc.

N/A

Current Price

$223.89

Market Cap

1.7B

Sector

Health Care

ML Signal

N/A

Logo Aurinia Pharmaceuticals Inc

AUPH

Aurinia Pharmaceuticals Inc

N/A

Current Price

$15.81

Market Cap

1.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UFPT
AUPH
Founded
1963
1993
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.6B
IPO Year
1993
1999

Fundamental Metrics

Financial Performance
Metric
UFPT
AUPH
Price
$223.89
$15.81
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$289.00
$17.25
AVG Volume (30 Days)
130.6K
1.6M
Earning Date
11-03-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
23.11
N/A
EPS
8.61
0.55
Revenue
$597,952,000.00
$265,808,000.00
Revenue This Year
$21.91
$21.22
Revenue Next Year
$5.39
$15.40
P/E Ratio
$25.34
$28.81
Revenue Growth
29.47
20.62
52 Week Low
$178.26
$6.55
52 Week High
$289.57
$16.48

Technical Indicators

Market Signals
Indicator
UFPT
AUPH
Relative Strength Index (RSI) 55.61 58.50
Support Level $213.72 $15.57
Resistance Level $222.04 $16.07
Average True Range (ATR) 8.27 0.49
MACD -0.25 -0.10
Stochastic Oscillator 80.70 66.17

Price Performance

Historical Comparison
UFPT
AUPH

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing AUR200, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.

Share on Social Networks: